prodcode,dmdcode,gemscriptcode,therapyevents,productname,ingredient,strength,formulation,routeofadministration,bnftext,v12,v13,v14,v15,v16,v17,v18,v19,v20,v21,slashcountinchapter,bnfchapter
69589,2.45657110000e+16,26692021,10,Alemtuzumab 12mg/1.2ml solution for infusion vials,Alemtuzumab,10mg/1ml,Solution for infusion,Intravenous,Anti-Lymphocyte Monoclonal Antibodies,May 2017,26692021,,,,,,,,,0,8020500
60707,1.71907110000e+16,98555020,1,Ofatumumab 100mg/5ml solution for infusion vials,Ofatumumab,20mg/1ml,Solution for infusion,Intravenous,Cytotoxic Drugs/Anti-Lymphocyte Monoclonal Antibodies,August 2014,17912001,,,,,,,,,1,8020500
70553,2.55035110000e+16,29577021,3,Obinutuzumab 1g/40ml solution for infusion vials,Obinutuzumab,25mg/1ml,Solution for infusion,Intravenous,Cytotoxic Drugs/Anti-Lymphocyte Monoclonal Antibodies,October 2017,29577021,,,,,,,,,1,8020500
73083,2.45618110000e+16,26693021,3,Lemtrada 12mg/1.2ml concentrate for solution for infusion vials (Genzyme Therapeutics Ltd),Alemtuzumab,10mg/1ml,Solution for infusion,Intravenous,Anti-Lymphocyte Monoclonal Antibodies,September 2018,26693021,,,,,,,,,0,8020500
